Quality control of biological pharmaceuticals

Attana AB, AstraZeneca, Akzo Nobel Pulp and Performance Chemicals AB and Karlstad University and three more partners have started a new project aiming at developing leading methods for quality control  of production of biological pharmaceuticals.


Thursday November 30th the project BIO-QC "Quality Control and Purification of New Biological Pharmaceuticals" was initiated.

Biological pharmaceuticals are proteins or similar molecules, which mimics molecules in the body and are injected in the body to stimulate the immune system.

- The overall ambition of the project is to provide criteria’s for quality control of biological pharmaceuticals, says professor Torgny Fornstedt at Karlstad University and project coordinator.

The project has a budget of approximately €2 million and includes seven different parties, Attana AB, AstraZeneca, Akzo Nobel Pulp and Performance Chemicals AB and Ridgeview Instruments AB and Karlstad University, Linné University and Örebro University.

Tags:

About Us

Attana was founded in 2002 with the vision of in-vitro characterization of molecular interactions mimicking in-vivo conditions. Since then, Attana has developed proprietary label free biosensors for biochemical, crude, sera, and cell-based assays. Attana’s products and research services are used by Big Pharma, biotech companies and academic institutions within the life sciences. To learn more about Attana’s contract research services and our label free cell-based biosensors, please visit www.attana.com or contact sales@attana.com.

Subscribe

Documents & Links